Evaluating the feasibility of integrating salivary testing for congenital CMV into the Newborn Hearing Screening Programme in the UK

European Journal of Pediatrics

Volumn 174, Issue 8, 2015, Pages 1117-1121

  Kadambari, Seilesh ^a   Luck, Suzanne ^a,g   Davis, Adrian ^b   Walter, Simone ^c   Agrup, Charlotte ^d   Atkinson, Claire ^e   Stimson, Laura ^a   Williams, Eleri ^f   Berrington, Janet ^f   Griffiths, Paul ^e   Sharland, Mike ^a  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^b PUBLIC HEALTH ENGLAND   (United Kingdom)

^c ST HELIER HOSPITAL   (United Kingdom)

^d MAYDAY UNIVERSITY HOSPITAL   (United Kingdom)

^e ROYAL FREE HOSPITAL   (United Kingdom)

^f ROYAL VICTORIA INFIRMARY   (United Kingdom)

^g Kingston Hospital Foundation Trust   (United Kingdom)

Author keywords

Congenital cytomegalovirus; Polymerase chain reaction; Sensorineural hearing loss

Indexed keywords

DNA POLYMERASE; VALGANCICLOVIR; VIRUS DNA;

ARTICLE; AUDITORY SCREENING; CYTOMEGALOVIRUS INFECTION; DIAGNOSTIC TEST; EVALUATION STUDY; FEASIBILITY STUDY; HUMAN; MAJOR CLINICAL STUDY; NEWBORN; NEWBORN SCREENING; NONHUMAN; PERCEPTION DEAFNESS; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SALIVARY TESTING; UNITED KINGDOM; CHEMISTRY; COST BENEFIT ANALYSIS; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; ENGLAND; FEMALE; GENETICS; HEARING TEST; MALE; PROCEDURES; SALIVA;

COST-BENEFIT ANALYSIS; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; FEMALE; HEARING TESTS; HUMANS; INFANT, NEWBORN; LONDON; MALE; NEONATAL SCREENING; REAL-TIME POLYMERASE CHAIN REACTION; SALIVA;

EID: 84938292139     PISSN: 03406199     EISSN: 14321076     Source Type: Journal    
DOI: 10.1007/s00431-015-2506-8     Document Type: Article

References (12)

1. Boppana SB, Ross SA, Shimamura M, Palmer AL, Ahmed A, Michaels MG, Sánchez PJ, Bernstein DI, Tolan RW Jr, Novak Z, Chowdhury N, Britt WJ, Fowler KB, National Institute on Deafness and Other Communication Disorders CHIMES Study (2011) Saliva polymerase-chain-reaction assay for cytomegalovirus screening in newborns. N Engl J Med 364(22):2111–2118. doi:10.1056/NEJMoa1006561
2. Cannon MJ, Griffiths PD, Aston V, Rawlinson WD (2014) Universal newborn screening for congenital CMV infection: what is the evidence of potential benefit? Rev Med Virol. doi:10.1002/rmv
3. Dollard SC, Grosse SD, Ross DS (2007) New estimates of the prevalence of neurological and sensory sequelae and mortality associated with congenital cytomegalovirus infection. Rev Med Virol 7:355–363. doi:10.1002/rmv
4. Griffiths PD, Baboonian C, Rutter D, Peckham C (1991) Congenital and maternal cytomegalovirus infections in a London population. Br J Obstet Gynaecol 98:135–140
5. Kenneson A, Cannon MJ (2007) Review and meta-analysis of the epidemiology of congenital cytomegalovirus (CMV) infection. Rev Med Virol 17:253–276. doi:10.1002/rmv
6. Kimberlin DW, Lin CY, Sánchez PJ, Demmler GJ, Dankner W, Shelton M, Jacobs RF, Vaudry W, Pass RF, Kiell JM, Soong SJ, Whitley RJ, National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group (2003) Effect of ganciclovir therapy on hearing in symptomatic congenital cytomegalovirus disease involving the central nervous system: a randomized, controlled trial. J Pediatr 143(1):16–25
7. Mattes FM, Hainsworth EG, Hassan-Walker AF, Burroughs AK, Sweny P, Griffiths PD, Emery VC (2005) Kinetics of cytomegalovirus load decrease in solid-organ transplant recipients after preemptive therapy with valganciclovir. J Infect Dis 191(1):89–92. doi:10.1086/425905
8. Short-term vs. long-term valganciclovir therapy for symptomatic congenital CMV infections (2013) https://clinicaltrials.gov/ct2/show/results/NCT00466817. Accessed 16 Jan 2015
9. Stehel EK, Shoup AG, Owen KE, Jackson GL, Sendelbach DM, Boney LF, Sánchez PJ (2008) Newborn hearing screening and detection of congenital cytomegalovirus infection. Pediatrics 121(5):970–975. doi:10.1542/peds. 2006-3441
10. Townsend CL, Peckham C, Tookey P (2011) Surveillance of congenital cytomegalovirus in the UK and Ireland. Arch Dis Child Fetal Neonatal Ed 96:398–403
11. Waters A, Jennings K, Fitzpatrick E, Coughlan S, Molloy EJ, De Gascun CF, Hall WW, Knowles SJ (2014) Incidence of congenital cytomegalovirus infection in Ireland: implications for screening and diagnosis. J Clin Virol 59(3):156–160. doi:10.1016/j.jcv.2013.12.007
12. Williams EJ, Kadambari S, Berrington JE, Luck S, Atkinson C, Walter S, Embleton ND, James P, Griffiths P, Davis A, Sharland M, Clark JE (2014) Feasibility and acceptability of targeted screening for congenital CMV-related hearing loss. Arch Dis Child Fetal Neonatal Ed. doi:10.1136/archdischild-2013-305276